PALFYDE
Live / Applied — Third extension granted (statement of use) (as of 09 Feb 2026)
What this means for you
Not registered yet, but its 04 May 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97920353
- Mark type
- Stylized text
- Filed
- 04 May 2023
- Published for opposition
- 09 Jul 2024
- Attorney of record
- Danny M. Awdeh
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in treating endocrine disorders and endocrine-related diseases; pharmaceutical preparations for the treatment of acromegaly, carcinoid syndrome, neuroendocrine tumors, and cancer; all for human use
Owner
- Crinetics Pharmaceuticals, Inc., San Diego, CA, US
- Crinetics Pharmaceuticals, Inc., San Diego, CA, US
Prosecution history
- 10 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Feb 2026 — SOU EXTENSION 3 GRANTED
- 09 Feb 2026 — SOU EXTENSION 3 FILED
- 09 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 28 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Aug 2025 — SOU EXTENSION 2 GRANTED
- 27 Aug 2025 — SOU EXTENSION 2 FILED
- 27 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Dec 2024 — SOU EXTENSION 1 GRANTED
- 05 Dec 2024 — SOU EXTENSION 1 FILED
- 05 Dec 2024 — SOU TEAS EXTENSION RECEIVED
- 03 Sept 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 09 Jul 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Jul 2024 — PUBLISHED FOR OPPOSITION